Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Mouse CD278/ICOS Polyclonal Antibody

Catalog #:   PMJ92101 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: Q9WVS0
Overview

Catalog No.

PMJ92101

Species reactivity

Mouse

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Mouse CD278/ICOS (Ser32-His130).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

Inducible T-cell costimulator (Activation-inducible lymphocyte immunomediatory molecule) (CD28 and CTLA-4-like protein) (CCLP) (CD28-related protein 1) (CRP-1) (CD antigen CD278)

Purification

Purified by antigen affinity column.

Accession

Q9WVS0

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with CD278/ICOS antibody (PMJ92101) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 24 kDa
    Observed MW: 24 kDa
References

Non-invasive imaging with ICOS-targeting monoclonal antibody for preclinical diagnosis of rheumatoid arthritis in a humanized mouse model., PMID:39905410

Complement Factor H Is an ICOS Ligand Modulating Tregs in the Glioma Microenvironment., PMID:39378431

In vitro modulation of T cells in myasthenia gravis by low-dose IL-2., PMID:39285833

Circular RNA CircZNF644 Facilitates Circulating Follicular Helper T Cells Response in Patients with Graves' Disease., PMID:38966668

Investigation of activation-induced markers (AIM) in porcine T cells by flow cytometry., PMID:38868498

ICOS agonist vopratelimab modulates follicular helper T cells and improves B cell function in common variable immunodeficiency., PMID:38621471

Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacy., PMID:38454393

Synovial inducible costimulator is correlated with severity in knee osteoarthritis., PMID:38441341

The response of CD27+CD38+ plasmablasts, CD24hiCD38hi transitional B cells, CXCR5-ICOS+PD-1+ Tph, Tph2 and Tfh2 subtypes to allergens in children with allergic asthma., PMID:38424520

Discovery of ICOS-Targeted Small Molecules Using Pharmacophore-Based Screening., PMID:37845178

ICOS gene polymorphisms in systemic lupus erythematosus: A case-control study., PMID:37338463

Optimal dosing regimen of CD73 blockade improves tumor response to radiotherapy through iCOS downregulation., PMID:37270182

Granulocyte-Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade., PMID:37262321

Interleukin-21 promotes Type-1 activation and cytotoxicity of CD56dimCD16bright natural killer cells during kidney allograft antibody-mediated rejection showing a new link between adaptive and innate humoral allo-immunity., PMID:37220805

Tumor-infiltrating mast cells stimulate ICOS+ regulatory T cells through an IL-33 and IL-2 axis to promote gastric cancer progression., PMID:37086778

Non-Redundant Roles of T Cell Costimulation Pathways in Inflammatory Arthritis Revealed by Dual Blockade of ICOS and CD28 with Acazicolcept (ALPN-101)., PMID:36862144

Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma., PMID:36826995

Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies., PMID:36450783

MiR-29a-3p negatively regulates circulating Tfh memory cells in patients with Graves' disease by targeting ICOS., PMID:36322282

Fluorophore-Conjugated Anti-ICOS Antibody Enables Precise Prediction of Therapeutic Response of the STING Agonist in Colorectal Cancer via NIRF Imaging., PMID:36018674

Agonizing over the Stimulatory Immune Checkpoint ICOS., PMID:35792807

The Ratio of CD226 and TIGIT Expression in Tfh and PD-1+ICOS+Tfh Cells Are Potential Biomarkers for Chronic Antibody-Mediated Rejection in Kidney Transplantation., PMID:35733922

First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response., PMID:35511938

Abnormal Shift in B Memory Cell Profile Is Associated With the Expansion of Circulating T Follicular Helper Cells via ICOS Signaling During Acute HIV-1 Infection., PMID:35222430

TNFR2 Signaling Enhances Suppressive Abilities of Human Circulating T Follicular Regulatory Cells., PMID:35149531

Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models., PMID:34986869

Pre-existing immunity and vaccine history determine hemagglutinin-specific CD4 T cell and IgG response following seasonal influenza vaccination., PMID:34795301

Characterising the Phenotypic Diversity of Antigen-Specific Memory B Cells Before and After Vaccination., PMID:34650561

Defining the RBPome of primary T helper cells to elucidate higher-order Roquin-mediated mRNA regulation., PMID:34471108

Impact of HIV-1 Infection and Antigen Class on T Follicular Helper Cell Responses to Pneumococcal Polysaccharide-Protein Conjugate Vaccine-13., PMID:33931485

Treatment of solid tumors using bispecific anti-PDL-1/ICOS antibody., PMID:33829869

Implication of TIGIT+ human memory B cells in immune regulation., PMID:33750787

Increased circulating PD-1hiCXCR5- peripheral helper T cells are associated with disease severity of active ulcerative colitis patients., PMID:33675861

Zearalenone and deoxynivalenol inhibited IL-4 receptor-mediated Th2 cell differentiation and aggravated bacterial infection in mice., PMID:33556388

First-in-human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN-101, a dual CD28/ICOS antagonist, in healthy adult subjects., PMID:33503289

Development of a 43 color panel for the characterization of conventional and unconventional T-cell subsets, B cells, NK cells, monocytes, dendritic cells, and innate lymphoid cells using spectral flow cytometry., PMID:33336868

ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells., PMID:33095875

Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET., PMID:33087332

A Patient with Novel ICOS Mutation Presented with Progressive Loss of B Cells., PMID:33040278

Correlations of the expression of γδ T cells and their co-stimulatory molecules TIGIT, PD-1, ICOS and BTLA with PR and PIBF in the peripheral blood and decidual tissues of women with unexplained recurrent spontaneous abortion., PMID:33017473

An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression., PMID:32999002

ICOS+ Tregs: A Functional Subset of Tregs in Immune Diseases., PMID:32983168

ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models., PMID:32970735

Targeting co-stimulatory molecules in autoimmune disease., PMID:32939077

Elevated expansion of follicular helper T cells in peripheral blood from children with acute measles infection., PMID:32873255

Decrease in immune function and the role of mitogen-activated protein kinase (MAPK) overactivation in apoptosis during T lymphocytes activation induced by zearalenone, deoxynivalenol, and their combinations., PMID:32679628

Can Molecular Imaging Measure T-cell Activation?, PMID:32669349

CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS., PMID:32508812

ICOS signaling promotes a secondary humoral response after re-challenge with Plasmodium chabaudi chabaudi AS., PMID:32348365

The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas., PMID:32281488

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Mouse CD278/ICOS Polyclonal Antibody [PMJ92101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only